Biology subjects

Ya, A.

Publications and source records attributed to Ya, A..

4 recordsLinked to original sources

bioRxiv2026

Rapid reduction in global chromatin loop size after acute STAG2 reconstitution in human cancer cells

Truncating mutations in the tumor suppressor STAG2, which encodes a component of the cohesin complex, are prevalent across diverse human cancers. Here, we report that acute reconstitution of physiological STAG2 levels in STAG2-mutant human glioblastoma multiforme cancer cells triggers a rapid reduction in the size of chromatin loops genome-wide. Despite this global change in chromatin loop size, early transcriptional responses to STAG2 restoration are limited to a small number of genes, most of which are induced by STAG2 reconstitution. Notably, the growth-suppressor EFEMP1 (Fibulin-3), a secreted glycoprotein that functions as an extracellular matrix-associated inhibitor of glioblastoma growth and invasion, was the only gene consistently induced across all experimental models. The most robust and conserved STAG2-induced genes all reside within intense chromatin loops whose anchors and overall intensity did not appear to change in response to STAG2 reconstitution. These findings suggest that inactivating mutations of STAG2 promote neoplastic transformation by alleviating a restriction on chromatin loop size, allowing for an expanded range of chromatin interactions that disrupts the maintenance of a tumor-suppressive transcriptome.

cancer biology↗

bioRxiv2024

Cell Competition Eliminates Aneuploid Human Pluripotent Stem Cells

Human pluripotent stem cells (hPSCs) maintain diploid populations for generations despite a persistently high rate of mitotic errors that cause aneuploidy, or chromosome imbalances. Consequently, to maintain genome stability, aneuploidy must inhibit hPSC proliferation, but the mechanisms are unknown. Here, we surprisingly find that homogeneous aneuploid populations of hPSCs proliferate unlike aneuploid non-transformed somatic cells. Instead, in mosaic populations, cell non-autonomous competition between neighboring diploid and aneuploid hPSCs eliminates less fit aneuploid cells. Aneuploid hPSCs with lower Myc or higher p53 levels relative to diploid neighbors are outcompeted but conversely gain a selective advantage when Myc and p53 relative abundance switches. Thus, although hPSCs frequently missegregate chromosomes and inherently tolerate aneuploidy, Myc- and p53-driven cell competition preserves their genome integrity. These findings have important implications for the use of hPSCs in regenerative medicine and for how diploid human embryos are established despite the prevalence of aneuploidy during early development.

cell biology↗

bioRxiv2022

A Pluripotent Developmental State Confers a Low Fidelity of Chromosome Segregation

Human pluripotent stem cells (hPSCs) frequently become aneuploid with abnormal chromosome numbers due to mitotic chromosome segregation errors during propagation in culture. Yet, we do not understand why hPSCs exhibit a low mitotic fidelity. Here we investigate the mechanisms responsible for mitotic errors in hPSCs and show that the primary cause is lagging chromosomes with improper merotelic chromosome microtubule attachments in anaphase. Accordingly, we can improve merotelic error correction and reduce lagging chromosome rates in hPSCs using small molecules that prolong mitotic duration or destabilize chromosome microtubule attachments providing chemical strategies to preserve genome stability. Strikingly, we also demonstrate that mitotic error rates correlate with developmental potential decreasing upon differentiation and loss of pluripotency and conversely increasing after reprogramming to a pluripotent state. Thus, chromosome segregation fidelity is inherently low in hPSCs and depends on developmental state in normal human cells.

cell biology↗

bioRxiv2020

Myomegalin regulates Hedgehog pathway by controlling PDE4D at the centrosome

Mutations in the Hedgehog (Hh) signaling are implicated in birth defects and cancers, including medulloblastoma, one of the most malignant pediatric brain tumors. Current Hh inhibitors face the challenge of drug resistance and tumor relapse, urging new insights in the Hh pathway regulation. Our previous study revealed how PDE4D controls global levels of cAMP in the cytoplasm to positively regulate Hh signaling; in the present study we found that a specific isoform PDE4D3 is tethered to the centrosome by myomegalin, a centrosome/Golgi associated protein. Myomegalin loss dislocates PDE4D3 from the centrosome, leading to local PKA over-activation and inhibition of the Hh signaling, leaving other PKA-related pathways unaffected. Myomegalin loss suppresses the proliferation of granule neuron precursors, and blocks the growth of medulloblastoma in mouse model. Our findings specify a new regulatory mechanism of the Hh pathway, and highlight an exciting therapeutic avenue for Hh-related cancers with reduced side effects.

cell biology↗